- Information for Patients
- Information for Physicians
- Rosacea Review Newsletter
- Research Grants Program
- Classification of Rosacea
- Grading of Rosacea
- Management Options For Rosacea
- Glossary
- Join Us
- How to Donate
- Press Room
- Links
- Home
Archives
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
- August 2007
- July 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- October 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- February 2006
- January 2006
Links
Scoring Aids Eye Research
Tuesday, October 9, 2007
Special care may be needed for rosacea patients with severe forms of ocular rosacea (eye symptoms), according to Dr. Sandra Cremers, instructor of ophthalmology at Harvard Medical School. As part of a National Rosacea Society (NRS) research grant, she recently developed a scoring system to identify severe cases of this rosacea subtype, which may affect half of all rosacea patients.
The new questionnaire, called the Severity Criteria of Ocular Rosacea (SCOR), includes more than 25 signs and symptoms of ocular rosacea observed by both physician and patient, including eye dryness, tearing and burning; history of styes; inflammation; and potentially vision-threatening corneal involvement. The system was presented in a poster at the recent annual meeting of the American Academy of Ophthalmology.
Although ocular rosacea is often very mild, in an NRS survey of 1,780 rosacea patients reporting ocular symptoms, only 27 percent said they had been diagnosed with the condition, possibly indicating underdiagnosis.
Left untreated, patients with severe ocular rosacea could endure potentially serious consequences, such as scarring within the eyelid or corneal damage that could lead to decreased vision.
Dr. Cremers noted that for mild symptoms such as dry eye, a humidifier or other means to raise the humidity at home or in work environments as well as artificial tears may be appropriate.
In addition, washing the eyelashes daily with diluted baby shampoo on a warm wet washcloth may help keep the tear glands clear and unblocked. A hot compress can be placed on the eye for five minutes before the diluted baby shampoo is used to gently clean the eyelid margins. Then the face may be rinsed with closed eyes until the eyelashes feel clean and towel-dried. An eye doctor may also prescribe a cream for the lashes, Dr. Cremers said.
The researchers are now using the SCOR questionnaire to identify patients with severe ocular rosacea to evaluate the role of angiogenesis, which is the formation of new blood vessels in the disorder. Dr. Cremers noted that while new blood vessel growth is important for normal development and wound healing, this process is also implicated in some diseases.
Also, rosacea triggers such as sunlight have been linked to an increase in substances that may cause angiogenesis or inflammation, such as vascular endothelial growth factor (VEGF). Dr. Cremers and her group are currently investigating whether samples from severe cases of ocular rosacea contain any of these natural substances.
